ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

BPMC Blueprint Medicines Corporation

102.81
0.42 (0.41%)
After Hours
Last Updated: 17:30:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Blueprint Medicines Corporation BPMC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.42 0.41% 102.81 17:30:00
Open Price Low Price High Price Close Price Prev Close
102.75 102.31 106.02 102.81 102.39
more quote information »

Recent News

Date Time Source Heading
5/24/202408:00EDGAR2Form 8-K - Current report
5/23/202417:05PRNUSBlueprint Medicines to Present the First Promising and Most..
5/17/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/17/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/15/202417:07EDGAR2Form 144 - Report of proposed sale of securities
5/15/202417:05EDGAR2Form 144 - Report of proposed sale of securities
5/10/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/06/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/06/202417:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/06/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
5/02/202407:00PRNUSBlueprint Medicines Reports Strong First Quarter 2024..
4/18/202408:00PRNUSBlueprint Medicines to Report First Quarter 2024 Financial..
4/11/202408:00PRNUSBlueprint Medicines to Host Webcast and Conference Call..
4/04/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
3/11/202418:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/11/202418:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/11/202418:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/11/202418:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/11/202418:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/11/202418:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/11/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/11/202418:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/11/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
3/06/202410:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202418:19EDGAR2Form 144 - Report of proposed sale of securities
3/01/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202416:03EDGAR2Form 144 - Report of proposed sale of securities
2/23/202408:00PRNUSBlueprint Medicines Highlights AYVAKIT® (avapritinib)..
2/22/202408:20EDGAR2Form 8-K - Current report
2/16/202416:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/15/202417:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/15/202407:05EDGAR2Form 8-K - Current report
2/15/202407:00PRNUSBlueprint Medicines Reports Fourth Quarter and Full Year..
2/14/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
2/01/202408:00PRNUSBlueprint Medicines to Report Fourth Quarter and Full Year..
1/29/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202416:13EDGAR2Form 144 - Report of proposed sale of securities
1/08/202408:03EDGAR2Form 8-K - Current report
1/08/202408:00PRNUSBlueprint Medicines Highlights 2024 Corporate Strategy and..
1/05/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..

Your Recent History

Delayed Upgrade Clock